A recent study by Huang et al. [76] pointed to the potential role of macrophage sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) in amplifying the inflammatory response in adipose and liver tissues, leading to metabolic disorders participating in the development of lean NAFLD with metabolic changes. This evidence concerns the gene SCAP and metabolic dysfunction-associated steatotic liver disease.